Rituximab Combined With MSCs in the Treatment of PNS (3-4 Stage of CKD)
A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 116 participants.
Also called NCT02966717
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 116 participants
- Sponsor
- Registry
-
NCT02966717
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT02966717. Randomized; no masking; primary purpose treatment. Start 2016-08 (registry gives no type); primary completion 2016-10 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Rituximab Combined With MSCs in the Treatment of PNS (3-4 Stage of CKD)
- Acronym
- CKD (chronic kidney disease)
- Condition
- Renal Insufficiency, Chronic
- Condition
- Nephrotic Syndrome
- Intervention (Drug)
- Rituximab
- Intervention (Drug)
- conventional therapy
- Intervention (Drug)
- Mesenchymal stem cells
- Lead sponsor
- Zhujiang Hospital
Record details
- Record id
cardio:ct-nct02966717- Content hash
63cf68fa60b0f37e56f6a894d5ed9ef6d4f330abbf1ef4d453eb13627ac485a1